Gluskin Sheff & Assoc Inc Becton Dickinson & CO Transaction History
Gluskin Sheff & Assoc Inc
- $957 Million
- Q1 2024
A detailed history of Gluskin Sheff & Assoc Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 17,801 shares of BDX stock, worth $4.05 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
17,801
Previous 16,469
8.09%
Holding current value
$4.05 Million
Previous $4.02 Million
9.69%
% of portfolio
0.46%
Previous 0.42%
Shares
19 transactions
Others Institutions Holding BDX
# of Institutions
1,730Shares Held
240MCall Options Held
640KPut Options Held
766K-
Vanguard Group Inc Valley Forge, PA26.2MShares$5.96 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$5.2 Billion0.13% of portfolio
-
State Street Corp Boston, MA13.5MShares$3.08 Billion0.15% of portfolio
-
Morgan Stanley New York, NY10.7MShares$2.44 Billion0.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.1MShares$2.31 Billion0.31% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $65B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...